» Articles » PMID: 6088580

Retention of the Glycoprotein IIb-IIIa Complex in the Isolated Platelet Cytoskeleton. Effects of Separable Assembly of Platelet Pseudopodal and Contractile Cytoskeletons

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1984 Sep 1
PMID 6088580
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the association of the putative platelet fibrinogen receptor (glycoprotein IIb-III(a) with the cytoskeleton, 125I-surface labeled human platelets washed by gel-filtration were activated under conditions which allow selective assembly of the platelet cytoskeleton. The four conditions were activation with arachidonate or phorbol 12-myristate 13-acetate (PMA) with and without pretreatment with cytochalasin E. Activation with arachidonate generates a complete cytoskeletal core (pseudopodal and contractile elements) while PMA activation forms only an actin plus actin-binding protein pseudopodal core. Pretreatment with cytochalasin E leads to actomyosin contractile core formation if arachidonate activated, and essentially blocks cytoskeletal development if PMA activated. Cytoskeletal cores from arachidonate or PMA-activated platelets retained 26 (+/- 3%) of the total 125I-IIIa. Pretreatment with cytochalasin E followed by arachidonate or PMA activation reduced the 125I-IIIa retention to near control levels (unactivated platelets: 4 +/- 2%). The role of aggregation vs. receptor occupancy in the retention of IIb-IIIa was assessed by activation of platelets with arachidonate in the presence of fibrinogen fragment D (0.6-12 mg/ml). Aggregation was blocked by increasing concentrations of fragment D reagent while cytoskeletal assembly was not altered. The IIIa retention correlated with extent of aggregation with maximal retention corresponding to full aggregation. To determine if cytoskeletal development is necessary for the expression of the fibrinogen binding site, binding studies were performed with unlabeled platelets and 125I-fibrinogen. The mean number of binding sites and the mean dissociation constant were not significantly different among the four activation conditions. Although the development of a platelet cytoskeletal core is not required for the expression of the fibrinogen binding site, the retention of the glycoprotein IIb-IIIa complex is dependent on fibrinogen-supported aggregation as well as the formation of the pseudopodal cytoskeleton.

Citing Articles

Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research.

George M, Bynum J, Nair P, Cap A, Wade C, Cox Jr C Platelets. 2018; 29(5):431-439.

PMID: 29580113 PMC: 6323006. DOI: 10.1080/09537104.2018.1453062.


Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.

Wang R, Shattil S, Ambruso D, Newman P J Clin Invest. 1997; 100(9):2393-403.

PMID: 9351872 PMC: 508438. DOI: 10.1172/JCI119780.


Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets.

Bertagnolli M, Beckerle M J Cell Biol. 1993; 121(6):1329-42.

PMID: 8509453 PMC: 2119702. DOI: 10.1083/jcb.121.6.1329.


Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.

Torti M, Ramaschi G, Sinigaglia F, Lapetina E, Balduini C Proc Natl Acad Sci U S A. 1994; 91(10):4239-43.

PMID: 8183895 PMC: 43760. DOI: 10.1073/pnas.91.10.4239.


PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.

Kloprogge E, Hasselaar P, Akkerman J Biochem J. 1986; 238(3):885-91.

PMID: 3800968 PMC: 1147218. DOI: 10.1042/bj2380885.


References
1.
Mustard J, Kinlough-Rathbone R, Packham M, Perry D, HARFENIST E, Pai K . Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. Blood. 1979; 54(5):987-93. View

2.
Marguerie G, Plow E, Edgington T . Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979; 254(12):5357-63. View

3.
Hagen I, Nurden A, Bjerrum O, Solum N, Caen J . Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest. 1980; 65(3):722-31. PMC: 371415. DOI: 10.1172/JCI109719. View

4.
Hartwig J, Stossel T . Cytochalasin B and the structure of actin gels. J Mol Biol. 1979; 134(3):539-53. DOI: 10.1016/0022-2836(79)90366-8. View

5.
Peerschke E, ZUCKER M, Grant R, Egan J, Johnson M . Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood. 1980; 55(5):841-7. View